Aspen Neuroscience priced IPO at $15 per share on Nasdaq, shares fall 2% after debut

Corroborated by 2 sources from 2 publishers

globalbusiness8h ago

TL;DR

Gilead-Backed Aspen Neuroscience Shares Decline 2% After US IPO.

Sources